Literature DB >> 15877545

Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration.

Feng Dong1, Xiaochun Zhang, Bruce Culver, Herbert G Chew, Robert O Kelley, Jun Ren.   

Abstract

Iron deficiency is associated with multiple health problems, including the cardiovascular system. However, the mechanism of action of iron-deficiency-induced cardiovascular damage is unclear. The aim of the present study was to examine the effect of dietary iron deficiency on cardiac ultrastructure, mitochondrial cytochrome c release, NOS (nitric oxide synthase) and several stress-related protein molecules, including protein nitrotyrosine, the p47phox subunit of NADPH oxidase, caveolin-1 and RhoA. Male weanling rats were fed with either control or iron-deficient diets for 12 weeks. Cardiac ultrastructure was examined by transmission electron microscopy. Western blot analysis was used to evaluate cytochrome c, endothelial and inducible NOS, NADPH oxidase, caveolin-1 and RhoA. Protein nitrotyrosine formation was measured by ELISA. Rats fed an iron-deficient diet exhibited increased heart weight and size compared with the control group. Heart width, length and ventricular free wall thickness were similar between the two groups. However, the left ventricular dimension and chamber volume were significantly enhanced in the iron-deficient group compared with controls. Ultrastructural examination revealed mitochondrial swelling and abnormal sarcomere structure in iron-deficient ventricular tissues. Cytochrome c release was significantly enhanced in iron-deficient rats. Protein expression of eNOS (endothelial NOS) and iNOS (inducible NOS), and protein nitrotyrosine formation were significantly elevated in cardiac tissue or mitochondrial extraction from the iron-deficient group. Significantly up-regulated NADPH oxidase, caveolin-1 and RhoA expression were also detected in ventricular tissue of the iron-deficient group. Taken together, these results suggest that dietary iron deficiency may have induced cardiac hypertrophy characterized by aberrant mitochondrial and irregular sarcomere organization, which was accompanied by increased reactive nitrogen species and RhoA expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15877545     DOI: 10.1042/CS20040278

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  58 in total

Review 1.  Transition metals and mitochondrial metabolism in the heart.

Authors:  Amy K Rines; Hossein Ardehali
Journal:  J Mol Cell Cardiol       Date:  2012-06-02       Impact factor: 5.000

2.  The role of iron, omega-3 Fatty acids, and vitamins in heart failure.

Authors:  Donald S Silverberg; Doron Schwartz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

3.  Mean corpuscular volume and red cell distribution width as predictors of left atrial stasis in patients with non-valvular atrial fibrillation.

Authors:  Rui Providência; Maria João Ferreira; Lino Gonçalves; Ana Faustino; Luís Paiva; Andreia Fernandes; Sérgio Barra; Joana Pimenta; António M Leitão-Marques
Journal:  Am J Cardiovasc Dis       Date:  2013-06-10

4.  Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients.

Authors:  Yao-Peng Hsieh; Ching-Hui Huang; Chia-Ying Lee; Hung-Lin Chen; Ching-Yuang Lin; Chia-Chu Chang
Journal:  World J Nephrol       Date:  2013-05-06

Review 5.  Intravenous iron in heart failure: beyond targeting anemia.

Authors:  Donald S Silverberg; Adrian Iaina; Doron Schwartz; Dov Wexler
Journal:  Curr Heart Fail Rep       Date:  2011-03

6.  Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study.

Authors:  Odilson M Silvestre; Alexandra Gonçalves; Wilson Nadruz; Brian Claggett; David Couper; John H Eckfeldt; James S Pankow; Stefan D Anker; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2016-12-14       Impact factor: 15.534

7.  Prediction of adverse cardiac events in dilated cardiomyopathy using cardiac T2* MRI and MIBG scintigraphy.

Authors:  Michinobu Nagao; Shingo Baba; Masato Yonezawa; Yuzo Yamasaki; Takeshi Kamitani; Takuro Isoda; Satoshi Kawanami; Yasuhiro Maruoka; Yoshiyuki Kitamura; Kohtaro Abe; Taiki Higo; Kenji Sunagawa; Hiroshi Honda
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-28       Impact factor: 2.357

Review 8.  Iron in kidney and heart failure: from theory to practice.

Authors:  Aslihan Yerlikaya; Mustafa C Bulbul; Baris Afsar; Tuncay Dagel; Gamze Aslan; Luminita Voroneanu; Dimitire Siriopol; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2017-09-22       Impact factor: 2.370

9.  Intravenous iron exposure and mortality in patients on hemodialysis.

Authors:  Dana C Miskulin; Navdeep Tangri; Karen Bandeen-Roche; Jing Zhou; Aidan McDermott; Klemens B Meyer; Patti L Ephraim; Wieneke M Michels; Bernard G Jaar; Deidra C Crews; Julia J Scialla; Stephen M Sozio; Tariq Shafi; Albert W Wu; Courtney Cook; L Ebony Boulware
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

10.  Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.

Authors:  Nihal Bakeer; Jeanne James; Swarnava Roy; Janaka Wansapura; Shiva Kumar Shanmukhappa; John N Lorenz; Hanna Osinska; Kurt Backer; Anne-Cecile Huby; Archana Shrestha; Omar Niss; Robert Fleck; Charles T Quinn; Michael D Taylor; Enkhsaikhan Purevjav; Bruce J Aronow; Jeffrey A Towbin; Punam Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.